Enhancement of Adenovirus Delivery after Ultrasound-Stimulated Therapy in a Cancer Model

Ultrasound in Medicine and Biology

Volumn 39, Issue 12, 2013, Pages 2374-2381

  Sorace, Anna G ^a   Warram, Jason M ^b   Mahoney, Marshall ^a   Zinn, Kurt R ^a,b,c,d   Hoyt, Kenneth ^a,b,c,d  

^a and Radiation Oncology   (United States)

^b University of Alabama at Birmingham   (United States)

^c Center for Telecommunications Education and Research   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Adenovirus; Cancer; Gene therapy; Microbubble contrast agent; Transduction; Ultrasound

Indexed keywords

BACTERIOPHAGES; BIOCHEMISTRY; DISEASES; GENE THERAPY; HISTOLOGY; TUMORS; ULTRASONICS;

ADENOVIRUS; BIOLUMINESCENCE IMAGING; CANCER; CANCER GENE THERAPY; LOCALIZED DELIVERY; MICROBUBBLE CONTRAST AGENTS; TRANSDUCTION; TRANSDUCTION EFFICIENCY;

PHYSIOLOGICAL MODELS;

ADENOVIRUS VECTOR; LUCIFERASE;

ADENOVIRUS INFECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CANCER GENE THERAPY; CANCER MODEL; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG RETENTION; DRUG UPTAKE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; SHAM PROCEDURE; TUMOR GROWTH; ULTRASOUND STIMULATED GENE THERAPY; ULTRASOUND THERAPY; VIRUS GENE; VIRUS INFECTIVITY;

ADENOVIRUS; CANCER; GENE THERAPY; MICROBUBBLE CONTRAST AGENT; TRANSDUCTION; ULTRASOUND;

ADENOVIRIDAE; ANIMALS; CELL LINE, TUMOR; ELECTROPORATION; HIGH-ENERGY SHOCK WAVES; HUMANS; MALE; MICE; MICE, NUDE; PROSTATIC NEOPLASMS; SONICATION; TRANSFECTION; TREATMENT OUTCOME;

EID: 84887816434     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2013.07.017     Document Type: Article

References (49)

1. Bazan-Peregrino M., Rifai B., Carlisle R.C., Choi J., Arvanitis C.D., Seymour L.W., Coussios C.C. Cavitation-enhanced delivery of a replicating oncolytic adenovirus to tumors using focused ultrasound. JControl Release 2013, 169:40-47.
2. Bekeredjian R., Grayburn P.A., Shohet R.V. Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. JAm Coll Cardiol 2005, 45:329-335.
3. Böhmer M.R., Chlon C.H., Raju B.I., Chin C.T., Shevchenko T., Klibanov A.L. Focused ultrasound and microbubbles for enhanced extravasation. JControl Release 2010, 148:18-24.
4. Borovjagin A.V., Krendelchtchikov A., Ramesh N., Yu D.C., Douglas J.T., Curiel D.T. Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors. Cancer Gene Ther 2005, 12:475-486.
5. Calliada F., Campani R., Bottinelli O., Bozzini A., Sommaruga M.G. Ultrasound contrast agents: Basic principles. Eur J Radiol 1998, 27(Suppl 2):S157-S160.
6. Casey G., Cashman J.P., Morrissey D., Whelan M.C., Larkin J.O., Soden D.M., Tangney M., O'Sullivan G.C. Sonoporation mediated immunogene therapy of solid tumors. Ultrasound Med Biol 2010, 36:430-440.
7. Caskey C.F., Qin S., Dayton P.A., Ferrara K.W. Microbubble tunneling in gel phantoms. JAcoust Soc Am 2009, 125:EL183-EL189.
8. Chen S., Ding J.H., Bekeredjian R., Yang B.Z., Shohet R.V., Johnston S.A., Hohmeier H.E., Newgard C.B., Grayburn P.A. Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology. Proc Natl Acad Sci USA 2006, 103:8469-8474.
9. Chin CT, Raju BJ, Shevchenko T, Klibanov AL. Control and reversal of tumor growth by ultrasound activated microbubbles. In: Proceedings, 2009 IEEE Ultrasonics Symposium, Rome, 20-23 September 2009:77-80.
10. Choi J.W., Kang E., Kwon O.J., Yun T.J., Park H.K., Kim P.H., Kim S.W., Kim J.H., Yun C.O. Local sustained delivery of oncolytic adenovirus with injectable alginate gel for cancer virotherapy. Gene Ther 2013 March 21, [Epub ahead of print]. 10.1038/gt.2013.10.
11. Choi J.W., Lee J.S., Kim S.W., Yun C.O. Evolution of oncolytic adenovirus for cancer treatment. Adv Drug Deliv Rev 2012, 64:720-729.
12. Cosgrove D. Ultrasound contrast agents: An overview. Eur J Radiol 2006, 60:324-330.
13. De Vrij J., Willemsen R.A., Lindholm L., Hoeben R.C., Bangma C.H., Barber C., Behr J.P., Briggs S., Carlisle R., Cheng W.S., Dautzenberg I.J., de Ridder C., Dzojic H., Erbacher P., Essand M., Fisher K., Frazier A., Georgopoulos L.J., Jennings I., Kochanek S., Koppers-Lalic D., Kraaij R., Kreppel F., Magnusson M., Maitland N., Neuberg P., Nugent R., Ogris M., Remy J.S., Scaife M., Schenk-Braat E., Schooten E., Seymour L., Slade M., Szyjanowicz P., Totterman T., Uil T.G., Ulbrich K., van der Weel L., van Weerden W., Wagner E., Zuber G. Adenovirus-derived vectors for prostate cancer gene therapy. Hum Gene Ther 2010, 21:795-805. for the GIANT Consortium.
14. UoI. Phase II Study of adenovirus/PSA vaccine in men with hormone-refractory prostate cancer (APP22) 2007, Department of Defense, National Library of Medicine, Bethesda, MD, Retrieved 2013. Available from, NLM Identifier: NCT00583024. http://clinicaltrials.gov/show/NCT00583024.
15. Dijkmans P.A., Juffermans L.J., Musters R.J., van Wamel A., ten Cate F.J., van Gilst W., Visser C.A., de Jong N., Kamp O. Microbubbles and ultrasound: From diagnosis to therapy. Eur J Echocardiogr 2004, 5:245-256.
16. Ferrara K., Pollard R., Borden M. Ultrasound microbubble contrast agents: Fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng 2007, 9:415-447.
17. Frenkel V. Ultrasound mediated delivery of drugs and genes to solid tumors. Adv Drug Deliv Rev 2008, 60:1193-1208.
18. Fukazawa T., Matsuoka J., Yamatsuji T., Maeda Y., Durbin M.L., Naomoto Y. Adenovirus-mediated cancer gene therapy and virotherapy [review]. Int J Mol Med 2010, 25:3-10.
19. Greber U.F., Willetts M., Webster P., Helenius A. Stepwise dismantling of adenovirus 2 during entry into cells. Cell 1993, 75:477-486.
20. Heath C.H., Sorace A., Knowles J., Rosenthal E., Hoyt K. Microbubble therapy enhances anti-tumor properties of cisplatin and cetuximab invitro and invivo. Otolaryngol Head Neck Surg 2012, 146:938-945.
21. Howard C.M., Forsberg F., Minimo C., Liu J.B., Merton D.A., Claudio P.P. Ultrasound guided site specific gene delivery system using adenoviral vectors and commercial ultrasound contrast agents. JCell Physiol 2006, 209:413-421.
22. Kaplan J.M. Adenovirus-based cancer gene therapy. Curr Gene Ther 2005, 5:595-605.
23. Kim K.H., Dmitriev I., O'Malley J.P., Wang M., Saddekni S., You Z., Preuss M.A., Harris R.D., Aurigemma R., Siegal G.P., Zinn K.R., Curiel D.T., Alvarez R.D. Aphase I clinical trial of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in patients with recurrent gynecologic cancer. Clin Cancer Res 2012, 18:3440-3451.
24. Klibanov A.L. Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest Radiol 2006, 41:354-362.
25. Koike H., Tomita N., Azuma H., Taniyama Y., Yamasaki K., Kunugiza Y., Tachibana K., Ogihara T., Morishita R. An efficient gene transfer method mediated by ultrasound and microbubbles into the kidney. JGene Med 2005, 7:108-116.
26. Lindner J.R. Microbubbles in medical imaging: Current applications and future directions. Nat Rev Drug Discov 2004, 3:527-532.
27. Lupold S.E., Rodriguez R. Adenoviral gene therapy, radiation, and prostate cancer. Rev Urol 2005, 7:193-202.
28. McDannold N., Arvanitis C.D., Vykhodtseva N., Livingstone M.S. Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: Safety and efficacy evaluation in rhesus macaques. Cancer Res 2012, 72:3652-3663.
29. Miller D.L., Quddus J. Diagnostic ultrasound activation of contrast agent gas bodies induces capillary rupture in mice. Proc Natl Acad Sci USA 2000, 97:10179-10184.
30. Nie F., Xu H.X., Lu M.D., Wang Y., Tang Q. Anti-angiogenic gene therapy for hepatocellular carcinoma mediated by microbubble-enhanced ultrasound exposure: An invivo experimental study. JDrug Target 2008, 16:389-395.
31. Patel P, Wood BJ, Frenkel V, Nguyen D. Enhancement of AdVgTRAIL Gene Therapy using pulsed-high intensity focused ultrasound (HIFU) in a human esophageal carcinoma model in mice. In: Proceedings, Radiological Society of North America meeting, Chicago,2007.
32. Price R.J., Skyba D.M., Kaul S., Skalak T.C. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation 1998, 98:1264-1267.
33. Shimamura M., Sato N., Taniyama Y., Kurinami H., Tanaka H., Takami T., Ogihara T., Tohyama M., Kaneda Y., Morishita R. Gene transfer into adult rat spinal cord using naked plasmid DNA and ultrasound microbubbles. JGene Med 2005, 7:1468-1474.
34. Shohet R.V., Chen S., Zhou Y.T., Wang Z., Meidell R.S., Unger R.H., Grayburn P.A. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 2000, 101:2554-2556.
35. Sirsi S.R., Borden M.A. Advances in ultrasound mediated gene therapy using microbubble contrast agents. Theranostics 2012, 2:1208-1222.
36. Sirsi S.R., Hernandez S.L., Zielinski L., Blomback H., Koubaa A., Synder M., Homma S., Kandel J.J., Yamashiro D.J., Borden M.A. Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors. JControl Release 2012, 157:224-234.
37. Song J., Chappell J.C., Qi M., VanGieson E.J., Kaul S., Price R.J. Influence of injection site, microvascular pressure and ultrasound variables on microbubble-mediated delivery of microspheres to muscle. JAm Coll Cardiol 2002, 39:726-731.
38. Sorace A.G., Saini R., Mahoney M., Hoyt K. Microbubble-mediated ultrasound therapy uptake effects in cell suspensions and cell monolayers. JUltrasound Med 2012, 31:S96.
39. Sorace A.G., Saini R., Rosenthal E., Warram J.M., Zinn K.R., Hoyt K. Optical fluorescent imaging to monitor temporal effects of microbubble-mediated ultrasound therapy. IEEE Trans Ultrason Ferroelectr Freq Control 2013, 60:281-289.
40. Sorace A.G., Warram J.M., Umphrey H., Hoyt K. Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer. JDrug Target 2012, 20:43-54.
41. Stieger S.M., Caskey C.F., Adamson R.H., Qin S., Curry F.R., Wisner E.R., Ferrara K.W. Enhancement of vascular permeability with low-frequency contrast-enhanced ultrasound in the chorioallantoic membrane model. Radiology 2007, 243:112-121.
42. Tamosiunas M., Jurkonis R., Mir L.M., Lukosevicius A., Venslauskas M.S., Satkauskas S. Adjustment of ultrasound exposure duration to microbubble sonodestruction kinetics for optimal cell sonoporation invitro. Technol Cancer Res Treat 2012, 11:375-387.
43. Treat L.H., McDannold N., Zhang Y., Vykhodtseva N., Hynynen K. Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma. Ultrasound Med Biol 2012, 38:1716-1725.
44. Tsunoda S., Mazda O., Oda Y., Iida Y., Akabame S., Kishida T., Shin-Ya M., Asada H., Gojo S., Imanishi J., Matsubara H., Yoshikawa T. Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart. Biochem Biophys Res Commun 2005, 336:118-127.
45. Wang J.F., Wu C.J., Zhang C.M., Qiu Q.Y., Zheng M. Ultrasound-mediated microbubble destruction facilitates gene transfection in rat C6 glioma cells. Mol Biol Rep 2009, 36:1263-1267.
46. Wang X., Liang H.D., Dong B., Lu Q.L., Blomley M.J. Gene transfer with microbubble ultrasound and plasmid DNA into skeletal muscle of mice: Comparison between commercially available microbubble contrast agents. Radiology 2005, 237:224-229.
47. Warram J.M., Sorace A.G., Saini R., Borovjagin A.V., Hoyt K., Zinn K.R. Systemic delivery of a breast cancer-detecting adenovirus using targeted microbubbles. Cancer Gene Ther 2012, 19:545-552.
48. Yun C.O. Adenovirus-mediated shRNA delivery to cancer. Advanced delivery and therapeutic applications of RNAi 2013, 309-326. Wiley, New York. K. Cheng, R.I. Mahato (Eds.).
49. Zhang Q., Wang Z., Ran H., Fu X., Li X., Zheng Y., Peng M., Chen M., Schutt C.E. Enhanced gene delivery into skeletal muscles with ultrasound and microbubble techniques. Acad Radiol 2006, 13:363-367.